Keyphrases
Adolescent Patients
8%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
7%
Autoimmune Disease
11%
Baseline Characteristics
8%
Calcinosis
17%
Childhood Arthritis
74%
Childhood Vasculitis
15%
Childhood-onset Systemic Lupus Erythematosus
11%
Clinical Features
8%
Consensus Treatment Plans
13%
Corticosteroids
7%
Disease Activity
18%
Disease-modifying Antirheumatic Drugs (DMARDs)
9%
European Medicines Agency
8%
First Year
10%
Flutter Analysis
6%
Granulomatosis with Polyangiitis
13%
High Disease Activity
7%
Inflammatory Bowel Disease
7%
Inflammatory Diseases
6%
Intra-articular Steroids
6%
Juvenile Arthritis Disease Activity Score
8%
Juvenile Dermatomyositis
33%
Kawasaki Disease
11%
Lupus
15%
Lupus Nephritis
6%
Microscopic Polyangiitis
9%
Newly Diagnosed
8%
Patient-reported Outcomes
18%
Patient-Reported Outcomes Measurement Information System (PROMIS)
7%
Pediatric
20%
Pediatric Rheumatologist
9%
Pediatric Rheumatology
14%
Pediatric Vasculitis
7%
Purpura
7%
Race-ethnicity
8%
Recapture
9%
Recapture Rate
7%
Recurrent Parotitis
6%
Research Partnerships
74%
Rheumatologic Diseases
7%
Rheumatology Research
75%
Sjgren's Syndrome
13%
Systemic Inflammation
8%
Systemic Juvenile Idiopathic Arthritis (sJIA)
100%
Systemic Lupus Erythematosus
11%
Tumour Necrosis Factor Inhibitor (TNFi)
13%
United States
7%
Uveitis
6%
Wegener
7%
Medicine and Dentistry
Adalimumab
6%
Adolescence
7%
ANCA Associated Vasculitis
8%
Arthritis
71%
Atrial Myxoma
6%
Azathioprine
6%
Biological Product
13%
Calciphylaxis
17%
Catatonia
6%
Cohort Analysis
7%
Disease Activity
18%
Disease Modifying Antirheumatic Drug
10%
Diseases
43%
Drug Hypersensitivity
6%
Electroconvulsive Therapy
6%
Eosinophilia
6%
Fatality
6%
Glucocorticoid
12%
Granulomatosis with Polyangiitis
6%
Gut
6%
Heart Myxoma
6%
Inflammatory Arthritis
7%
Inflammatory Bowel Disease
7%
Interleukin 1
9%
Interleukin 6
11%
Juvenile Dermatomyositis
26%
Juvenile Idiopathic Arthritis
66%
Lupus Erythematosus
8%
Lupus Nephritis
6%
Medicine
6%
Nephritic Syndrome
7%
Observational Study
13%
Parotitis
6%
Patient-Reported Outcome
19%
Pediatric Rheumatology
14%
Pediatrics
33%
Purpura
7%
Rheumatoid Arthritis
7%
Rheumatology
75%
Scurvy
6%
Silo-Filler's Disease
7%
Social Determinants of Health
6%
Systemic Juvenile Idiopathic Arthritis
28%
Systemic Lupus Erythematosus
25%
Systemic Therapy
7%
Tamponade
6%
TNF Inhibitor
11%
Toddlers
6%
Vasculitis
25%
Walking Difficulty
6%